X-ray lightsource at DESY identifies promising candidates for COVID drugs
Electron density map of the most antiviral active ingredient calpeptin (yellow) binding at the main protease. © DESY/Sebastian Günther
At DESY's high-brilliance X-ray light source PETRA III, a team from more than 30 research institutions has identified several candidates for active substances against the coronavirus SARS-CoV-2. They bind to an important protein of the virus and could thus be the basis for a drug against Covid-19. The MX team from HZB examined part of the measurement data with special analysis algorithms in order to identify suitable active substances. The study has now been published in the renowned journal Science.
In a so-called X-ray screening, the researchers, under the leadership of DESY, tested almost 6000 known active substances that already exist for the treatment of other diseases in a short amount of time. After measuring about 7000 samples, the team was able to identify a total of 37 substances that bind to the main protease (Mpro) of the SARS-CoV-2 virus, as the scientists report online today in the journal Science. Seven of these substances inhibit the activity of the protein and thus slow down the multiplication of the virus. Two of them do this so promisingly that they are currently under further investigation in preclinical studies. This drug screening – probably the largest of its kind – also revealed a new binding site on the main protease of the virus to which drugs can couple.
“The active substances Calpeptin and Pelitinib clearly showed the highest antivirality with good cell compatibility. Our cooperation partners have therefore already started preclinical investigations with these two substances,” explains DESY researcher Sebastian Günther, first author of the Science publication.
In addition to DESY scientists, researchers from the Universities of Hamburg and Lübeck, the Bernhard Nocht Institute for Tropical Medicine, the Fraunhofer Institute for Translational Medicine and Pharmacology, the Heinrich Pette Institute, the European XFEL, the European Molecular Biology Laboratory EMBL, the Max Planck Society, the Helmholtz-Zentrum Berlin and other institutions are involved in the work.
Note: This is a shortened version of the full text of the press release published at DESY Website.
- Small powerhouses for very special lightAn international team presents the functional principle of a new source of synchrotron radiation in Nature Communications Physics. Steady-state microbunching (SSMB) allows to build efficient and powerful radiation sources for coherent UV radiation in the future. This is very attractive for applications in basic research as well in the semiconductor industry.
- New Method for Absorption Correction to Improve Dental FillingsA research team led by Dr. Ioanna Mantouvalou has developed a method to more accurately depict the elemental distributions in dental materials than previously possible. The used confocal micro-X-ray fluorescence (micro-XRF) analysis provides three-dimensional elemental images that contain distortions. These distortions occur when X-rays pass through materials of different densities and compositions. By utilizing micro-CT data, which provides detailed 3D images of the material structure, and chemical information from X-ray absorption spectroscopy (XAS) experiments conducted in the laboratory (BLiX, TU Berlin) and at the synchrotron light source BESSY II, the researchers have improved the method.
- Helmholtz Institute for Polymers in Energy Applications (HIPOLE Jena) InauguratedOn June 17, 2024, the Helmholtz Institute for Polymers in Energy Applications (HIPOLE Jena) was officially inaugurated in Jena in the presence of Wolfgang Tiefensee, Minister for Economy, Science, and Digital Society of the Free State of Thuringia. The institute was founded by the Helmholtz Center Berlin for Materials and Energy (HZB) in cooperation with the Friedrich Schiller University Jena. It is dedicated to developing sustainable polymer materials for energy technologies, which are expected to play a key role in the energy transition and support Germany’s goal of becoming climate-neutral by 2045.